Monod Bio
PrivateLast Round
Grant
Oct 15, 2025
Total Funding Raised
$27.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Monod Bio is a biotechnology company that develops AI-powered de novo protein binders and biosensors for research and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Sensors
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Monod Bio Comparables
Compare Monod Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tierra Biosciences | 70% | |
| A-Alpha Bio | 64% | |
| Gator Bio | 63% |
Monod Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 15, 2025 | ||||
| Grant | Sep 3, 2025 | ||||
| Seed | Aug 15, 2022 |
Monod Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boom Capital Ventures | Seed |
| Boom Capital | Seed |
| Gates Family Foundation | Grant |
| Gates Foundation | Grant |
| Pack Ventures | Seed |
| Bill & Melinda Gates Foundation | Grant |
| Washington Research Foundation Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2026
Robert J. Bujarski appointed to the Board of Directors.
- Dec 3, 2025
Integrated with Gator Bio for next-generation biosensing capabilities.
Recent news
Latest coverage and updates
- integrates_withAug 26, 2026
Monod Bio, Inc. integrated with SignalChem Biotech Inc. on Aug 26th '26.
Monod Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Monod Bio's valuation, stock price, and market status.
Is Monod a public or private company?
Monod is a private company.
What is the current stock price of Monod?
Monod is a private company with no public stock price. No recent secondary market data is available.
How much is Monod worth (valuation)?
Valuation information for Monod is not publicly available.
Can I buy Monod stock?
Monod shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Monod's last funding round?
Monod's most recent funding round was Grant on September 3, 2025.
Who are the main investors in Monod?
Key investors in Monod include Boom Capital Ventures, Gates Family Foundation, Gates Foundation, Pack Ventures, Washington Research Foundation Capital.
Will Monod IPO soon?
No public IPO plans have been announced for Monod.
How can I track Monod secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Monod's secondary market activity and sign up for updates.